Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Research & Development: 2014-2025

Historic Research & Development for Aytu Biopharma (AYTU) over the last 10 years, with Jun 2025 value amounting to $216,000.

  • Aytu Biopharma's Research & Development fell 79.27% to $216,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $1.3 million, marking a year-over-year decrease of 52.11%. This contributed to the annual value of $1.3 million for FY2025, which is 52.11% down from last year.
  • According to the latest figures from Q2 2025, Aytu Biopharma's Research & Development is $216,000, which was up 33.33% from $162,000 recorded in Q1 2025.
  • Over the past 5 years, Aytu Biopharma's Research & Development peaked at $4.8 million during Q2 2021, and registered a low of $162,000 during Q1 2025.
  • Its 3-year average for Research & Development is $541,600, with a median of $521,500 in 2023.
  • In the last 5 years, Aytu Biopharma's Research & Development surged by 1,464.69% in 2021 and then crashed by 85.71% in 2023.
  • Over the past 5 years, Aytu Biopharma's Research & Development (Quarterly) stood at $4.5 million in 2021, then crashed by 61.79% to $1.7 million in 2022, then plummeted by 69.53% to $521,000 in 2023, then increased by 0.19% to $522,000 in 2024, then crashed by 79.27% to $216,000 in 2025.
  • Its Research & Development stands at $216,000 for Q2 2025, versus $162,000 for Q1 2025 and $522,000 for Q4 2024.